Skip to content

Vivani Medical VANI Neurostimulation Division — Total Assets

Other segment segments

Biopharm Division
$41.9M+20.7%
Neuromodulation Division
$500K-28.6%

Similar metrics at other companies

LivaNova logo
LIVNNeuromodulation — Total Assets
$650.1M+1.3%
Fulgent Genetics, Inc. logo
FLGTTherapeutic Development — Total Assets
$109.14M+22.8%
OSI Systems logo
OSISHealthcare Division — Total Assets
$284.2M+6.4%
Atkore logo
ATKRElectrical — Total Assets
$1.5B+2.8%
Emerson Electric logo
EMRIntelligent Devices — Total Assets
$11.96B
IDEX logo
IEXHealth & Science Technologies — Total Assets
$4.29B+2.6%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's neurostimulation division — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's neurostimulation division — total assets?
Vivani Medical (VANI) reported neurostimulation division — total assets of $500K in Q4 2025.
What does neurostimulation division — total assets mean?
Represents the total economic resources controlled by the neurostimulation division, including property, equipment, and intangible assets. This metric reflects the capital intensity of the segment and the scale of its infrastructure. Investors use this to evaluate the asset base supporting the division's research and development or commercial activities.